Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results

Paris, France and Camberley, UK – 16 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the proposed accounting treatment of the ongoing DHSC dispute on its unaudited H1 2021 interim results for the six months ended 30 June 2021. The interim results are expected to be announced

Visit Page

AGM voting

Paris, France and Camberley, UK – 13 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM) as a closed meeting at 2pm CEST/1pm BST on Wednesday, 29 September 2021. As usual, and in accordance with French corporate law, the AGM comprises

Visit Page

Notice of AGM

Paris, France and Camberley, UK – 20 August 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its Annual General Meeting (AGM) will be held as a closed meeting at 2pm CEST/1pm BST on Wednesday, 29 September 2021. The AGM comprises both ordinary and extraordinary general meetings. http://novacyt.com/wp-content/uploads/2021/08/Novacyt-Notice-of-AGM-Aug-2021.pdf

Visit Page